Drug Shortage Report for VENLAFAXINE XR
| Report ID | 183733 |
| Drug Identification Number | 02516543 |
| Brand name | VENLAFAXINE XR |
| Common or Proper name | Venlafaxine Hydrochloride |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | VENLAFAXINE |
| Strength(s) | 75MG |
| Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
| Route of administration | ORAL |
| Packaging size | 500 |
| ATC code | N06AX |
| ATC description | ANTIDEPRESSANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-02-06 |
| Estimated end date | 2024-08-20 |
| Actual end date | 2024-08-28 |
| Shortage status | Resolved |
| Updated date | 2024-08-29 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2023-02-06 | French | Compare |
| v1 | 2023-02-06 | English | Compare |